About Our Lab

The scientific goal of the Nacev Lab is to understand how cancer-associated genetic alterations in chromatin regulators promote cancer and to leverage this understanding to advance new therapeutic approaches in the clinic. Specifically, we model these events and study how the epigenome is dysregulated to alter transcriptional and developmental programs important for cancer growth and oncogenic behavior. To do so, we employ diverse tools including genetic, chemical, and epigenomic approaches.

The philosophy of the Nacev lab is to create a welcoming and inclusive environment that promotes creative thinking, innovation, and that embraces the joy and excitement of discovery.

Our mission is to pursue science in the service of helping people with cancer to live longer and better lives.

Research

Oncohistones

Oncohistones

Histone proteins are the core subunits of the nucleosome particle, which undergoes chemical modifications and rearrangements to regulate gene function. We study how cancer-associated mutations in histones (‘oncohistones’) disrupt the histone code and dysregulate chromatin.

Chromatin Dysregulation in Sarcomas

Chromatin Dysregulation in Sarcomas

Sarcomas are a family of cancers, which derive from mesenchymal tissues (e.g. muscle, bone, fat, etc). Pathologic genetic events in chromatin regulators in sarcomas are common. We study how these affect chromatin and chromatin-regulated processes in order to understand disease biology and develop better treatment.

Featured Publications

Nacev BA*, Sanchez-Vega F*, Smith SA, Antonescu CR, Rosenbaum E, Shi H, Tang C, Socci ND, Rana S, Gularte-Mérida R, Zehir A, Gounder MM, Bowler TG, Luthra A, Jadeja B, Okada A, Strong JA, Stoller J, Chan JE, Chi P, D’Angelo SP, Dickson MA, Kelly CM, Keohan ML, Movva S, Thornton K, Meyers PA, Wexler LH, Slotkin EK, Glade Bender JL, Shukla NN, Hensley ML, Healey JH, La Quaglia MP, Alektiar KM, Crago AM, Yoon SS, Untch BR, Chiang S, Agaram NP, Hameed MR, Berger MF, Solit DB, Schultz N, Ladanyi M, Singer S, Tap WD. Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets. Nat Commun. 2022; PMID: 35705560

Nacev BA, Jones KB, Intlekofer AM, Yu JSE, Allis CD, Tap WD, Ladanyi M, Nielsen TO. The epigenomics of sarcoma. Nat Rev Cancer. 2020 PMID: 32782366.

Nacev BA, Feng L, Bagert JD, Lemiesz AE, Gao J, Soshnev AA, Kundra R, Schultz N, Muir TW, Allis CD. The expanding landscape of ‘oncohistone’ mutations in human cancers. Nature. 2019 Mar 20. 2019 Mar;567(7749):473-478.

Featured News

Welcome Steve!

Welcome Steve!

News Image
Welcome Carter and Lucas

Welcome Carter and Lucas

News Image
Welcome to the lab, Julia!

Welcome to the lab, Julia!

News People